DOXORUBICIN HYDROCHLORIDE — all Canadian products
25 DINs
9 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DOXORUBICIN HYDROCHLORIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02238389 | CAELYX | BAXTER CORPORATION | Suspension | Intravenous | DOXORUBICIN HYDROCHLORIDE 2 MG | Marketed | |
| 02410397 | DOXORUBICIN | PFIZER CANADA ULC | Solution | Intravenous; Intravesical | DOXORUBICIN HYDROCHLORIDE 2 MG | Marketed | |
| 02194473 | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP | PFIZER CANADA ULC | Powder For Solution | Intravenous; Intravesical | DOXORUBICIN HYDROCHLORIDE 150 MG | Marketed | |
| 02194465 | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP | PFIZER CANADA ULC | Powder For Solution | Intravesical; Intravenous | DOXORUBICIN HYDROCHLORIDE 50 MG | Marketed | |
| 02400626 | DOXORUBICIN HYDROCHLORIDE INJECTION | OMEGA LABORATORIES LIMITED | Solution | Intravenous; Intravesical | DOXORUBICIN HYDROCHLORIDE 2 MG | Approved | |
| 02409275 | DOXORUBICIN HYDROCHLORIDE INJECTION | TEVA CANADA LIMITED | Solution | Intravenous; Intravesical | DOXORUBICIN HYDROCHLORIDE 2 MG | Marketed | |
| 02381982 | DOXORUBICIN INJECTION, BP | ACCORD HEALTHCARE INC | Solution | Intravenous; Intravesical | DOXORUBICIN HYDROCHLORIDE 2 MG | Marketed | |
| 02544857 | PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE FOR INJECTION | DR REDDY'S LABORATORIES LTD | Suspension | Intravenous | DOXORUBICIN HYDROCHLORIDE 2 MG | Approved | |
| 02493020 | TARO-DOXORUBICIN LIPOSOMAL | TARO PHARMACEUTICALS INC | Suspension | Intravenous | DOXORUBICIN HYDROCHLORIDE 2 MG | Marketed | |
| 02071002 | ADRIAMYCIN PFS | PFIZER CANADA ULC | Solution | Intravesical; Intravenous | DOXORUBICIN HYDROCHLORIDE 2 MG | Dormant | |
| 02069555 | ADRIAMYCIN RDF | PFIZER CANADA ULC | Powder For Solution | Intravenous | DOXORUBICIN HYDROCHLORIDE 50 MG | Cancelled Post Market | |
| 02069563 | ADRIAMYCIN RDF | PFIZER CANADA ULC | Powder For Solution | Intravenous | DOXORUBICIN HYDROCHLORIDE 150 MG | Cancelled Post Market | |
| 02065657 | ADRIAMYCIN RDF | PFIZER CANADA ULC | Powder For Solution | Intravenous | DOXORUBICIN HYDROCHLORIDE 10 MG | Cancelled Post Market | |
| 00357391 | ADRIAMYCIN RDF INJ 10MG/VIAL | CARLO ERBA FARMITALIA SPA | Powder For Solution | Intravenous | DOXORUBICIN HYDROCHLORIDE 10 MG | Cancelled Post Market | |
| 00768766 | ADRIAMYCIN RDF INJ 150MG/VIAL | ADRIA LABORATORIES OF CANADA LTD. | Powder For Solution | Intravenous | DOXORUBICIN HYDROCHLORIDE 150 MG | Cancelled Post Market | |
| 00353078 | ADRIAMYCIN RDF INJ 50MG/VIAL | CARLO ERBA FARMITALIA SPA | Powder For Solution | Intravenous | DOXORUBICIN HYDROCHLORIDE 50 MG | Cancelled Post Market | |
| 02093057 | DOXORUBICIN HCL FOR INJ. U.S.P. 10MG/VIAL | DAVID BULL LABORATORIES (PTY) LTD. | Powder For Solution | Intravenous | DOXORUBICIN HYDROCHLORIDE 10 MG | Cancelled Post Market | |
| 02093081 | DOXORUBICIN HCL FOR INJ. U.S.P. 150MG/VIAL | DAVID BULL LABORATORIES (PTY) LTD. | Powder For Solution | Intravenous | DOXORUBICIN HYDROCHLORIDE 150 MG | Cancelled Post Market | |
| 02093073 | DOXORUBICIN HCL FOR INJ. U.S.P. 50MG/VIAL | DAVID BULL LABORATORIES (PTY) LTD. | Powder For Solution | Intravenous | DOXORUBICIN HYDROCHLORIDE 50 MG | Cancelled Post Market | |
| 02467240 | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP | PANDA PHARMACEUTICALS INC. | Powder For Solution | Intravenous | DOXORUBICIN HYDROCHLORIDE 50 MG | Cancelled Pre Market | |
| 02194457 | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP | PFIZER CANADA ULC | Powder For Solution | Intravesical; Intravenous | DOXORUBICIN HYDROCHLORIDE 10 MG | Cancelled Pre Market | |
| 02375710 | DOXORUBICIN HYDROCHLORIDE INJECTION | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Intravesical | DOXORUBICIN HYDROCHLORIDE 2 MG | Cancelled Post Market | |
| 02230108 | DOXORUBICIN HYDROCHLORIDE INJECTION | NOVOPHARM LIMITED | Solution | Intravenous | DOXORUBICIN HYDROCHLORIDE 2 MG | Cancelled Post Market | |
| 02413973 | DOXORUBICIN HYDROCHLORIDE INJECTION, USP | STRIDES PHARMA CANADA INC | Solution | Intravesical; Intravenous | DOXORUBICIN HYDROCHLORIDE 2 MG | Dormant | |
| 02245015 | MYOCET | SOPHERION THERAPEUTICS LLC | Liposomes | Intravenous | DOXORUBICIN HYDROCHLORIDE 2 MG | Dormant |
Browse other molecules: